Effect of the consumption of a synbiotic diet mousse containing Lactobacillus acidophilus La-5 by individuals with metabolic syndrome: A randomized controlled trial

Journal of Functional Foods

Volumn 41, Issue , 2018, Pages 55-61

  Xavier Santos, Douglas ^a   Lima, Egidio Dorea ^a   Simão, Andréa Name Colado ^b   Bedani, Raquel ^a   Saad, Susana Marta Isay ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University Hospital of Londrina   (Brazil)

Author keywords

Clinical trial; Metabolic syndrome; Mousse; Prebiotic; Probiotic

Indexed keywords

EID: 85038875124     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2017.12.041     Document Type: Article

References (56)

1. Ahn, H.-Y., Kim, M., Chae, J.S., Ahn, Y.-T., Sim, J.-H., Choi, Il.-D., Lee, J.H., Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and L. plantarum KY1032, reduces fasting TG and enhances apolipoprotein A-V levels in non-diabetic subjects with hypertriglyceridemia. Atherosclerosis 241 (2015), 649–656.
2. Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Esmaillzadeh, A., Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition 32 (2016), 315–320.
3. Akoğlu, B., Loytved, A., Nuiding, H., Zeuzem, S., Faust, D., Probiotic Lactobacillus casei Shirota improves kidney function, inflammation and bowel movements in hospitalized patients with acute gastroenteritis – A prospective study. Journal of Functional Foods 17 (2015), 305–313.
4. Al-Sheraji, S.H., Ismail, A., Manap, M.Y., Mustafa, S., Yusof, R.M., Hassan, F.A., Hypocholesterolemic effect of yoghurt containing Bifidobacteriumpseudocatenulatum G4 or Bifidobacteriumlongum BB536. Food Chemistry 135 (2012), 356–361.
5. Amine, K.M., Champagne, C.P., Raymond, Y., St-Gelais, D., Britten, M., Fustier, P., Lacroix, M., Survival of microencapsulated Bifidobacterium longum in Cheddar cheese during production and storage. Food Control 37 (2014), 193–199.
6. Ashraf, R., Vasiljevic, T., Day, S.L., Smith, S.C., Donkor, O.N., Lactic acid bacteria and probiotic organisms induce different cytokine profile and regulatory T cells mechanisms. Journal of Functional Foods 6 (2014), 395–409.
7. Barreto, F.M., Simão, A.N.C., Morimoto, H.K., Lozovoy, M.A.B., Dichi, I., Miglioranza, L.H.S., Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome. Nutrition 30 (2014), 939–942.
8. Bernini, L.J., Simão, A.N.C., Alfieri, D.F., Lozovoy, M.A.B., Mari, N.L., Souza, C.H.B., Costa, G.N., Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome. Nutrition 32 (2016), 716–719.
9. Brito-Luna, M.J., Villanueva-Quintero, D.G., Sandoval-Talamantes, A.K., Fatutis-Morris, M., Graciano-Machuca, O., Sanchez-Hernandez, P.E., Alvarado-Navarro, A., Correlation of IL-12, IL-22, and IL-23 in patients with psoriasis and metabolic syndrome. Preliminary report. Cytokine 85 (2016), 130–136.
10. Buriti, F.C.A., Castro, I.A., Saad, S.M.I., Viability of Lactobacillus acidophilus in synbiotic guava mousses and its survival under in vitro simulated gastrointestinal conditions. International Journal of Food Microbiology 137 (2010), 121–129.
11. Cani, P.D., Hul, M.V., Novel opportunities for next-generation probiotics targeting metabolic syndrome. Current Opinion in Biotechnology 32 (2015), 21–27.
12. Champagne, C.P., Ross, R.P., Saarela, M., Hansen, K.F., Charalampopoulos, D., Recommendations for viability assessment of probiotics as concentrated cultures and in food matrices. International Journal of Food Microbiology 149 (2011), 185–193.
13. Chuang, T.-J., Liu, J.-S., Li, P.-F., Wen Chang, H., Hsieh, C.-H., Chang, J.-B., Chen, Y.-L., The relationships between hematogram and metabolic syndrome in elderly subgroups: A Taiwan cohort study. Archives of Gerontology and Geriatrics 63 (2016), 59–66.
14. Cominetti, C., Marreiro, D. N., & Cozzolino, S. M. F. (2012). Minerais e obesidade. In S. M. F. Cozzolino (Ed.), Biodisponibilidade de nutrientes (4th ed., pp. 971–1005). Barueri: Manole. cap.40.
15. de Moreno de LeBlanc, A., Perdigon, G., The application of probiotic fermented milks in cancer and intestinal inflammation. The Proceedings of the Nutrition Society 69 (2010), 421–428.
16. Forssten, S.D., Sindelar, C.W., Ouwehand, A.C., Probiotics from an industrial perspective. Anaerobe 17 (2011), 410–413.
17. Gøbel, R.J., Larsen, N., Jakobsen, M., Mølgaard, C., Michaelsen, K.F., Probiotics to adolescents with obesity: Effects on inflammation and metabolic syndrome. Journal of Pediatric Gastroenterology and Nutrition 55 (2012), 673–678.
18. Gonzalez-Quintela, A., Alende, R., Gude, F., Campos, J., Rey, J., Meijide, L.M., Vidal, C., Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clinical and Experimental Immunology 151 (2008), 42–50.
19. Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Costa, F., Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005), 2735–2752.
20. Guo, Z., Liu, X.M., Zhang, Q.X., Shen, Z., Tian, F.W., Zhang, H., Zhang, H.P., Influence of consumption of probiotics on the plasma lipid profile: A meta-analysis of randomised controlled trials. Nutrition, Metabolism & Cardiovascular Disease 21 (2011), 844–850.
21. Health Canada (2009). Guidance document – The use of probiotic microorganisms in food. Available at: < http://www.hc-sc.gc.ca/fn-an/alt_formats/hpfb-dgpsa/pdf/legislation/probiotics_guidance-orientation_probiotiques-eng.pdf> Accessed May 25th, 2016.
22. Hu, Y.-H., Kuo, S.-W., Wu, D.-A., Relationships between hemoglobin and each component of metabolic syndrome: A special focus on elderly without medication. International Journal of Gerontology 10 (2016), 22–27.
23. Ishimwe, N., Daliri, E.B., Lee, B.H., Fang, F., Du, G., The perspective on cholesterol-lowering mechanisms of probiotics. Molecular Nutrition & Food Research 59 (2015), 94–105.
24. Jolma, P., Kööbi, P., Kalliovalkama, J., Kähönen, M., Fan, M., Saha, H., Pörsti, I., Increased calcium intake reduces plasma cholesterol and improves vaso relaxation in experimental renal failure. American Journal of Physiology Heart and Circulatory Physiology 285 (2003), H1882–H1889.
25. Jonkers, D.M.A.E., Role of microbes (probiotics and prebiotics). Best Practice & Research Clinical Gastroenterology 6 (2016), 181–183.
26. Jung, S., Lee, Y.J., Kim, M., Kim, M., Kwak, J.H., Lee, J.-W., Lee, J.-H., Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduced body adiposity and Lp-PLA 2 activity in overweight subjects. Journal of Functional Foods 19 (2015), 744–752.
27. Kakafika, A.I., Liberopoulos, E.N., Karagiannis, A., Athyros, V.G., Mikhailidis, D.P., Dyslipidaemia, hypercoagulability and the metabolic syndrome. Current Vascular Pharmacology 4 (2006), 175–283.
28. Karaman, A., Aydin, H., Geçkinli, B., Çetinkaya, A., Karaman, S., DNA damage is increased in lymphocytes of patients with metabolic syndrome. Mutation Research 782 (2015), 30–35.
29. Kovatcheva-Datchary, P., Arora, T., Nutrition, the gut microbiome and the metabolic syndrome. Best Practice & Research Clinical Gastroenterology 27 (2013), 59–72.
30. Larsen, N., Vogensen, F.K., van den Berg, F.W.J., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., Jakobsen, M., Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE, 5, 2010, e9085.
31. Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. PNAS 102 (2005), 11070–11075.
32. Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: Human gut microbes associated with obesity. Nature 44 (2006), 1022–1023.
33. Ma, Y., Liu, J., Shi, H., Yu, L., Isolation and characterization of anti-inflammatory peptides derived from whey protein. Journal of Dairy Science 99 (2016), 6902–6912.
34. Madjene, L.C., Pons, M., Danelli, L., Claver, J., Ali, L., Madera-Salcedo, I.K., Blank, U., Mast cells in renal inflammation and fibrosis: Lessons learnt from animal studies. Molecular Immunology 63 (2015), 86–93.
35. Matsusaki, T., Takeda, S., Takeshita, M., Arima, Y., Tsend-Ayush, C., Oyunsuren, T., Kurokawa, M., Augmentation of T helper type 1 immune response through intestinal immunity in murine cutaneous herpes simplex virus type 1 infection by probiotic Lactobacillus plantarum strain 06CC2. International Immunopharmacology 39 (2016), 320–327.
36. Mazidi, M., Rezaie, P., Kengne, A.P., Mobarhan, M.G., Ferns, G.A., Gut microbiome and metabolic syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 10S (2016), S150–S157.
37. Mill, J.G., Pinto, K., Griep, R.H., Goulart, A., Foppa, M., Lotufo, P.A., Bensenor, I.M., Aferições e exames clínicos realizados nos participantes do ELSA-Brasil. Revista de Saúde Pública 47 (2013), 54–62.
38. Ministero della Salute (2013). Commissione unica per la nutrizione e la dietetica – Guidelines on probiotics and prebiotics. Available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_1016_allegato.pdf Accessed May 24th, 2016.
39. Panahi, Y., Hosseini, M.S., Khalili, N., Naimi, E., Simental-Mendía, L.E., Majeed, M., Sahebkar, A., Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. Biomedicine & Pharmacotherapy 82 (2016), 578–582.
40. Sanders, M.E., Marco, M.L., Food formats for effective delivery of probiotics. Annual Review of Food Science and Technology 1 (2010), 65–85.
41. Scavuzzi, B.M., Miglioranza, L.H.S., Henrique, F.C., Paroschi, T.P., Lozovoy, M.A.B., Simaão, A.N.C., Dichi, I., The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks. Expert Opinion on Therapeutic Targets 19 (2015), 1127–1138.
42. Shimakawa, T., Bild, D.E., Relationship between hemoglobin and cardiovascular risk factors in young adults. Journal of Clinical Epidemiology 46 (1993), 1257–1266.
43. Simão, T.N.C., Lozovoy, M.A.B., Simão, A.N.C., Oliveira, S.R., Venturini, D., Morimoto, H.K., Dichi, I., Reduced-energy cranberry juice increases folic acid and adiponectin and reduces homocysteine and oxidative stress in patients with the metabolic syndrome. British Journal of Nutrition 110 (2013), 1885–1894.
44. Singh, B.P., Vij, S., Hati, S., Functional significance of bioactive peptides derived from soybean. Peptides 54 (2014), 171–179.
45. Solieri, L., Rutella, G.S., Tagliazucchi, D., Impact of non-starter lactobacilli on release of peptides with angiotensin-converting enzyme inhibitory and antioxidant activities during bovine milk fermentation. Food Microbiology 51 (2015), 108–116.
46. Song, K., Du, H., Zhang, Q., Wang, C., Guo, Y., Wu, H., Niu, K., Serum immunoglobulin M concentration is positively related to metabolic syndrome in an adult population: Tianjin chronic low-grade systemic inflammation and health (TCLSIH) cohort study. PLoS ONE, 9, 2014, e88701.
47. Štofilová J., Szabadosová V., Hrčková G., Salaj, R., Bertková I., Hijová E., Bomba, A., Co-administration of a probiotic strain Lactobacillus plantarum LS/07 CCM7766 with prebiotic inulin alleviates the intestinal inflammation in rats exposed to N, N-dimethylhydrazine. International Immunopharmacology 24 (2015), 361–368.
48. Synetos, A., Papanikolaou, A., Toutouzas, K., Georgiopoulos, G., Karanasos, A., Drakopoulou, M., Tousoulis, D., Metabolic syndrome predicts plaque rupture in patients with acute myocardial infarction. An optical coherence study. International Journal of Cardiology 209 (2016), 139–141.
49. Tonucci, L.B., Santos, K.M.O., Oliveira, L.L.O., Ribeiro, S.M.R., Martino, H.S.D., Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clinical Nutrition 36 (2017), 85–92.
50. Tremaroli, V., Bäckhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
51. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Gordon, J.I., A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
52. Vaskonen, T., Mervaala, E., Sumuvuori, V., Seppänen-Laakso, T., Karppanen, H., Effects of calcium and plant sterols on serum lipids in obese Zucker rats on a low-fat diet. British Journal of Nutrition 87 (2002), 239–245.
53. Wang, Z., Shen, X.-H., Feng, W.-M., Qiu, W., Mast cell specific immunological biomarkers and metabolic syndrome among middle-aged and older Chinese adults. Endocrine Journal 64 (2017), 245–253.
54. Wang, Z., Zhang, H., Shen, X.-H., Jin, K.-L., Ye, G.-F., Qian, L., Shi, G.-P., Immunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus. Ploes One, 6, 2011, e28962.
55. Wang, Z., Zhang, H., Shen, X.-H., Jin, K.-L., Ye, G.-F., Qiu, W., Shi, G.-P., Increased levels of IgE in plasma or tissues may activate mast cells and increase mast cell mediators in the extracellular milieu. Annals of Medicine 45 (2013), 220–229.
56. Zhang, J., Shi, G.P., Mast cells and metabolic syndrome. Biochimicaet Biophysica Acta 1822 (2012), 14–20.